In the cancer hallmark gene set, the high-risk group exhibited significant upregulation of pathways related to epithelial-mesenchymal transition and angiogenesis, while suppressing immune pathways such as IFN-α and IFN-β responses, as well as oxidative phosphorylation (Fig. 6A). The gene discussed is IFNB1; the disease is cancer.